CoChat

Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis

Open access

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The purpose of this review is to examine the effect of Omega-3 Fatty acids on mortality, morbidity, and adverse events in patients with acute myocardial infarction (AMI). METHODS: Data Sources: MEDLINE, EMBASE, and the Cochrane Library through May 2018. STUDY SELECTION: Randomized Controlled trials (RCT). Certainty of evidence was assessed with the GRADE system. INTERVENTIONS: omega 3 fatty acids against placebo or no treatment. Primary and secondary outcomes: All-cause death, cardiovascular death, new AMI, stroke, need for therapeutic angioplasty or By-pass, new diagnosis of cancer and incidence of adverse events. RESULTS: For the efficacy endpoints we included 10 RCT (24,414 patients). Omega 3 fatty acids probably make little or no difference to all-cause mortality (4 studies 9141 patients RR 1.06 - CI95% 0.90 to 1.27, moderate certainty), cardiovascular mortality (3 studies 4304 patients RR 0.93 - CI95% 0.63 to 1.37, moderate certainty), new AMI (RR 1.24 CI95% 0.71 to 2.14 - moderate certainty), any cardiovascular event (RR 0.95 95%CI 0.86 to 1.05; low certainty due to risk of bias and imprecision), and stroke (RR 1.2 95%CCI 0,66-2,19 - moderate certainty). Regarding adverse events, we are uncertain if Omega 3 fatty acids improve/reduce non severe adverse events (RR 1.39 95% CI 0.36 to 5.34; very low certainty). There is probably little or no difference in the outcome suspension due to adverse events (RR 1.19 CI 95% 0.97 to 1.47; moderate certainty). CONCLUSIONS: For adult patients with AMI, omega 3 fatty-acids probably yield no benefit to patient important outcomes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12872-019-1086-3

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Flow chart of study selection
Fig. 1 Flow chart of study selectionCC BY · PubMed Central
Fig. 2 Risk-of-Bias of included studies
Fig. 2 Risk-of-Bias of included studiesCC BY · PubMed Central
Fig. 3 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.1 All-cause mortality - Risk of bias subgroup
Fig. 3 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.1 All-cause mortality - Risk of bias subgroupCC BY · PubMed Central
Fig. 4 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.2 Cardiovascular mortality - Risk of bias subgroup
Fig. 4 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.2 Cardiovascular mortality - Risk of bias subgroupCC BY · PubMed Central
Fig. 5 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.3 Acute myocardial infarction- Risk of bias subgroup
Fig. 5 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.3 Acute myocardial infarction- Risk of bias subgroupCC BY · PubMed Central
Fig. 6 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.4 Stroke - Risk of bias subgroup
Fig. 6 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.4 Stroke - Risk of bias subgroupCC BY · PubMed Central
Fig. 7 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.5 Need to revascularization - Risk of bias subgroup
Fig. 7 Forest plot of comparison: Omega 3 vs. Placebo, outcome: 1.5 Need to revascularization - Risk of bias subgroupCC BY · PubMed Central
Fig. 8 Forest plot of comparison: Treatment suspension due to adverse events
Fig. 8 Forest plot of comparison: Treatment suspension due to adverse eventsCC BY · PubMed Central
Fig. 9 Forest plot of comparison: Cancer
Fig. 9 Forest plot of comparison: CancerCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 7

  1. Foundation., B.N n-3 fatty acids and health: briefing paper 1999 London British Nutrition Foundation
  2. University, C.G.a.M Tools to assess risk of bias in cohort and case control studies; randomized controlled trials; and longitudinal symptom research studies aimed at the general population 2013
  3. Schünemann H Brożek J Guyatt G Oxman A GRADE handbook for grading quality of evidence and strength of recommendations 2013
  4. National Center for Biotechnology Information. PubChem Compound Database; CID=5280934. https://pubchem.ncbi.nlm.nih.gov/compound/5280934. Accessed 5 May 2019.
  5. UK., F.S.A., Dioxins and PCBs in the UK diet: 1997 Total diet study samples. Food Surveillance Information Sheet. 2000(Vol. 4/00. [ FSIS 4/00]).
  6. MacLean CH Newbery SJ Mujica WA Issa A Khanna P Lim YW Effects of omega-3 fatty acids on cancer. Evidence Report/Technology Assessment 2005 Rockville (MD) Agency for Healthcare Research and Quality E010 E012
  7. National Clinical Guideline, C. Myocardial infarction: cardiac rehabilitation and prevention of further MI NICE guidelines [CG172]. 2013. 31891465

Cited by

See all 19

Metadata

Authors
Popoff, F., Balaciano, G., Bardach, A., Comandé, D., Irazola, V., Catalano, H. N., & Izcovich, A.
Affiliations
  • Ministerio de Salud (AR)
  • Hospital Alemán (AR)
  • Instituto de Efectividad Clínica y Sanitaria (AR)
Corresponding author
  • Popoff, Federico
  • Balaciano, Giselle
Venue
BMC Cardiovascular Disorders
Published
2019-06-04
Volume
19
Issue
1
Pages
136-136
ISSN
1471-2261 (ISSN-L)
OpenAlex
W2948075275
Cited by
19
References
40
Citations by year
2025: 1 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 2
FWCI
0.41
Type
journal article
Language
en
Open access
Licence
Locations
  • BMC Cardiovascular Disorders (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • CONICET Digital (CONICET) (submittedVersion, cc-by)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
Keywords
omega-3 fatty acids, acute myocardial infarction, mortality, cardiovascular mortality, reinfarction, stroke, adverse events, lipid-lowering therapy, cardiovascular events
MeSH terms
Cause of Death, Humans, Myocardial Infarction, Recurrence, Risk Factors, Time Factors, Fatty Acids, Omega-3, Treatment Outcome, Risk Assessment, Dietary Supplements, Secondary Prevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s12872-019-1086-3
The paper
Popoff, F., Balaciano, G., Bardach, A., Comandé, D., Irazola, V., Catalano, H. N., & Izcovich, A. (2019). Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-019-1086-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.